1. Home
  2. RKLB vs BMRN Comparison

RKLB vs BMRN Comparison

Compare RKLB & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RKLB
  • BMRN
  • Stock Information
  • Founded
  • RKLB 2006
  • BMRN 1996
  • Country
  • RKLB United States
  • BMRN United States
  • Employees
  • RKLB N/A
  • BMRN N/A
  • Industry
  • RKLB Aerospace
  • BMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RKLB Industrials
  • BMRN Health Care
  • Exchange
  • RKLB Nasdaq
  • BMRN Nasdaq
  • Market Cap
  • RKLB 10.6B
  • BMRN 12.1B
  • IPO Year
  • RKLB N/A
  • BMRN 1999
  • Fundamental
  • Price
  • RKLB $20.51
  • BMRN $58.86
  • Analyst Decision
  • RKLB Buy
  • BMRN Buy
  • Analyst Count
  • RKLB 13
  • BMRN 22
  • Target Price
  • RKLB $24.05
  • BMRN $93.43
  • AVG Volume (30 Days)
  • RKLB 13.5M
  • BMRN 1.6M
  • Earning Date
  • RKLB 05-08-2025
  • BMRN 05-01-2025
  • Dividend Yield
  • RKLB N/A
  • BMRN N/A
  • EPS Growth
  • RKLB N/A
  • BMRN 152.82
  • EPS
  • RKLB N/A
  • BMRN 2.71
  • Revenue
  • RKLB $466,016,000.00
  • BMRN $2,950,227,000.00
  • Revenue This Year
  • RKLB $35.30
  • BMRN $12.27
  • Revenue Next Year
  • RKLB $54.49
  • BMRN $9.86
  • P/E Ratio
  • RKLB N/A
  • BMRN $21.76
  • Revenue Growth
  • RKLB 64.98
  • BMRN 19.36
  • 52 Week Low
  • RKLB $3.98
  • BMRN $52.93
  • 52 Week High
  • RKLB $33.34
  • BMRN $94.85
  • Technical
  • Relative Strength Index (RSI)
  • RKLB 47.31
  • BMRN 37.63
  • Support Level
  • RKLB $21.50
  • BMRN $58.74
  • Resistance Level
  • RKLB $23.20
  • BMRN $61.26
  • Average True Range (ATR)
  • RKLB 1.20
  • BMRN 1.98
  • MACD
  • RKLB 0.01
  • BMRN -0.03
  • Stochastic Oscillator
  • RKLB 37.55
  • BMRN 1.80

About RKLB Rocket Lab USA Inc.

Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

Share on Social Networks: